{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:54:07Z","timestamp":1781772847612,"version":"3.54.5"},"reference-count":152,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Bacteria represent a vast and underexplored reservoir of bioactive compounds with significant anticancer potential. Numerous bacterial taxa, particularly actinomycetes, Bacillus, Pseudomonas, and marine-derived species, produce structurally diverse metabolites exhibiting cytotoxic, cytostatic, pro-apoptotic, immunomodulatory, and anti-angiogenic activities against cancer cells. Clinically established agents such as actinomycin D and bleomycin highlight the therapeutic relevance of bacterial natural products, while recent discoveries continue to expand the repertoire of bioactive polyketides, peptides, alkaloids, and proteins. These compounds act through multiple mechanisms, including DNA intercalation, induction of apoptosis, cell cycle arrest, metabolic disruption, and modulation of the tumor microenvironment. Advances in metagenomics, genome mining, and synthetic biology have enabled the identification and activation of previously silent biosynthetic gene clusters, significantly enhancing drug discovery potential. In addition to metabolite-based anticancer agents, advances in synthetic biology have enabled the development of engineered bacterial platforms capable of selectively colonizing tumors, delivering therapeutic molecules, and activating prodrug therapies within the tumor microenvironment. Despite ongoing challenges related to toxicity, limited yield, selectivity, and clinical translation, bacterial-derived compounds remain a promising frontier in oncology. This review summarizes bacterial sources, bioactive metabolites, molecular mechanisms, preclinical and clinical applications, and future prospects for developing effective and safe anticancer strategies.<\/jats:p>","DOI":"10.1093\/lambio\/ovag050","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:44:56Z","timestamp":1780573496000},"source":"Crossref","is-referenced-by-count":0,"title":["Bacteria as anticancer agents: bioactive metabolites, engineered platforms, and translational mechanisms"],"prefix":"10.1093","volume":"79","author":[{"given":"Manel","family":"Gharbi","sequence":"first","affiliation":[{"name":"Group of Bacteriology and Biotechnology Development, Laboratory of Epidemiology and Veterinary Microbiology, Pasteur Institute of Tunis, University of Tunis El Manar (UTM) , Tunis 1002 ,","place":["Tunisia"]},{"name":"University of Jendouba, Higher Institute of Biotechnology of Beja , 9000 Beja ,","place":["Tunisia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9673-193X","authenticated-orcid":false,"given":"Mohamed Salah","family":"Abbassi","sequence":"additional","affiliation":[{"name":"University of Tunis El Manar, Tunisian institute of veterinary research, Laboratory of bacteriological research , 1006 Tunis ,","place":["Tunisia"]},{"name":"University of Tunis El Manar, Faculty of Medicine of Tunis, Laboratory of Antibiotic Resistance LR99ES09 , 1006 Tunis ,","place":["Tunisia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"2026061804164073400_bib1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3390\/biom14010117","article-title":"The identification and heter ologous expression of the biosynthetic gene cluster encoding the antibiotic and anticancer agent Marinomycin","volume":"14","author":"Abraham","year":"2024","journal-title":"Biomolecules"},{"key":"2026061804164073400_bib2","doi-asserted-by":"publisher","first-page":"100300","DOI":"10.1016\/j.crbiot.2025.100300","article-title":"Marine-derived secondary metabolites in oncology: a comprehensive review","volume":"10","author":"Abuzahrah","year":"2025","journal-title":"Curr Res Biotechnol"},{"key":"2026061804164073400_bib3","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.3390\/pharmaceutics14102100","article-title":"Salmonella as a promising curative tool against cancer","volume":"14","author":"Aganja","year":"2022","journal-title":"Pharmaceutics"},{"key":"2026061804164073400_bib4","doi-asserted-by":"publisher","first-page":"968053","DOI":"10.3389\/fmicb.2022.968053","article-title":"Streptomyces: the biofactory of secondary metabolites","volume":"13","author":"Alam","year":"2022","journal-title":"Front Microbiol"},{"key":"2026061804164073400_bib5","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.3390\/biomedicines11041054","article-title":"Streptomyces bioactive metabolites prevent liver cancer through apoptosis, inhibiting oxidative stress and inflammatory markers in diethylnitrosamine-induced hepatocellular carcinoma","volume":"11","author":"Alhawsawi","year":"2023","journal-title":"Biomedicines"},{"key":"2026061804164073400_bib6","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s12223-025-01332-x","article-title":"Anticancer compounds from streptomyces: insights from metagenomics and mechanistic perspective","volume":"70","author":"Al-Shaibani","year":"2025","journal-title":"Folia Microbiol"},{"key":"2026061804164073400_bib7","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.3390\/cancers17152487","article-title":"Engineered bifidobacterium strains colonization at tumor sites: a novel approach to the delivery of cancer treatments","volume":"17","author":"Amonkar","year":"2025","journal-title":"Cancers"},{"key":"2026061804164073400_bib8","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1007\/s13346-024-01649-z","article-title":"Natural compounds-based nanomedicines for cancer treatment: future directions and challenges","volume":"14","author":"Andreani","year":"2024","journal-title":"Drug Deliv Transl Res"},{"key":"2026061804164073400_bib9","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1021\/np800617a","article-title":"Arenamides a-C, cytotoxic NFkappaB inhibitors from the marine actinomycete Salinispora arenicola","volume":"72","author":"Asolkar","year":"2009","journal-title":"J Nat Prod"},{"key":"2026061804164073400_bib10","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.biochi.2020.07.020","article-title":"Bacteria and bacterial anticancer agents as a promising alternative for cancer therapeutics","volume":"177","author":"Baindara","year":"2020","journal-title":"Biochimie"},{"key":"2026061804164073400_bib11","first-page":"981","article-title":"Synthetic biology, genome mining, and combinatorial biosynthesis of actinomycetes","volume":"34","author":"Baltz","year":"2017","journal-title":"Nat Prod Rep"},{"key":"2026061804164073400_bib12","doi-asserted-by":"publisher","first-page":"kuad024","DOI":"10.1093\/jimb\/kuad024","article-title":"Diversity and taxonomic distribution of bacterial biosynthetic gene clusters predicted to produce compounds with therapeutically relevant bioactivities","volume":"50","author":"Beck","year":"2023","journal-title":"J Ind Microbiol Biotechnol"},{"key":"2026061804164073400_bib13","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1038\/s41598-020-58904-9","article-title":"Genome mining of biosynthetic and chemotherapeutic gene clusters in Streptomyces bacteria","volume":"10","author":"Belknap","year":"2020","journal-title":"Sci Rep"},{"key":"2026061804164073400_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ja.2005.1","article-title":"Bioactive microbial metabolites","volume":"58","author":"B\u00e9rdy","year":"2005","journal-title":"J Antibiot (Tokyo)"},{"key":"2026061804164073400_bib15","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1080\/02648725.2022.2131961","article-title":"Biotechnological impacts of Halomonas: a promising cell factory for industrially relevant biomolecules","volume":"39","author":"Biswas","year":"2023","journal-title":"Biotechnol Genet Eng Rev"},{"key":"2026061804164073400_bib16","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/ja.2006.12","article-title":"New aminophenoxazinones from a marine Halomonas sp.: fermentation, structure elucidation, and biological activity","volume":"59","author":"Bitzer","year":"2006","journal-title":"J Antibiot"},{"key":"2026061804164073400_bib17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1039\/C7NP00052A","article-title":"Marine natural products","volume":"35","author":"Blunt","year":"2018","journal-title":"Nat Prod Rep"},{"key":"2026061804164073400_bib18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1053\/ctrv.2000.0202","article-title":"Mitomycin C: a clinical update","volume":"27","author":"Bradner","year":"2001","journal-title":"Cancer Treat Rev"},{"key":"2026061804164073400_bib19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cbi.2010.04.016","article-title":"Growth inhibition and pro-apoptotic activity of violacein in Ehrlich ascites tumor","volume":"186","author":"Bromberg","year":"2010","journal-title":"Chem Biol Interact"},{"key":"2026061804164073400_bib20","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41586-021-04003-2","article-title":"Metabolic modulation of tumours with engineered bacteria for immunotherapy","volume":"598","author":"Canale","year":"2021","journal-title":"Nature"},{"key":"2026061804164073400_bib21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3390\/toxins12040241","article-title":"Talkin' toxins: from Coley\u2019s to modern cancer immunotherapy","volume":"12","author":"Carlson","year":"2020","journal-title":"Toxins"},{"key":"2026061804164073400_bib22","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/bjc.2013.206","article-title":"Myeloid-derived suppressor cells have a central role in attenuated Listeria monocytogenes-based immunotherapy against metastatic breast cancer in young and old mice","volume":"108","author":"Chandra","year":"2013","journal-title":"Br J Cancer"},{"key":"2026061804164073400_bib23","doi-asserted-by":"publisher","first-page":"14546","DOI":"10.3390\/ijms150814546","article-title":"Salmonella as an innovative therapeutic antitumor agent","volume":"15","author":"Chang","year":"2014","journal-title":"Int J Mol Sci"},{"key":"2026061804164073400_bib24","doi-asserted-by":"publisher","first-page":"lxae048","DOI":"10.1093\/jambio\/lxae048","article-title":"Lipopeptides from Bacillus velezensis induced apoptosis-like cell death in the pathogenic fungus fusarium concentricum","volume":"135","author":"Chen","year":"2024","journal-title":"J Appl Microbiol"},{"key":"2026061804164073400_bib25","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1038\/s44321-024-00159-2","article-title":"Salmonella cancer therapy metabolically disrupts tumours at the collateral cost of T cell immunity","volume":"16","author":"Copland","year":"2024","journal-title":"EMBO Mol Med"},{"key":"2026061804164073400_bib26","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1016\/j.bbagen.2013.02.008","article-title":"Natural products: a continuing source of novel drug leads","volume":"1830","author":"Cragg","year":"2013","journal-title":"Biochimica et Biophysica Acta (BBA)\u2014Gen Subj"},{"key":"2026061804164073400_bib27","doi-asserted-by":"publisher","first-page":"872223","DOI":"10.3389\/fonc.2022.872223","article-title":"Characterization of anti-cancer activities of violacein: actions on tumor cells and the tumor microenvironment","volume":"12","author":"Dahlem","year":"2022","journal-title":"Front Oncol"},{"key":"2026061804164073400_bib28","doi-asserted-by":"publisher","first-page":"18473","DOI":"10.1038\/s41598-023-45910-w","article-title":"The anticancer and antibacterial potential of bioactive secondary metabolites derived from bacterial endophytes in association with Artemisia absinthium","volume":"13","author":"Damavandi","year":"2023","journal-title":"Sci Rep"},{"key":"2026061804164073400_bib29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jpha.2019.03.004","article-title":"Anticancer potential of metabolic compounds from marine actinomycetes isolated from Lagos Lagoon sediment","volume":"9","author":"Davies-Bolorunduro","year":"2019","journal-title":"J Pharm Anal"},{"key":"2026061804164073400_bib30","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.tiv.2006.06.007","article-title":"Cytotoxic activity of violacein in human colon cancer cells","volume":"20","author":"de\u00a0Carvalho","year":"2006","journal-title":"Toxicol In Vitro"},{"key":"2026061804164073400_bib31","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3390\/molecules26041109","article-title":"Plant-derived anticancer compounds as new perspectives in drug discovery and alternative therapy","volume":"26","author":"Dehelean","year":"2021","journal-title":"Molecules"},{"key":"2026061804164073400_bib32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/bacteria4040051","article-title":"Antitumor potential of bioactive crude extracts derived from Actinomycetes","volume":"4","author":"Dhaini","year":"2025","journal-title":"Bacteria"},{"key":"2026061804164073400_bib33","doi-asserted-by":"publisher","first-page":"514","DOI":"10.2174\/1389203721666201207231932","article-title":"Microbial enzymes used in prodrug activation for cancer therapy: insights and future perspectives","volume":"22","author":"Dhankhar","year":"2021","journal-title":"CPPS"},{"key":"2026061804164073400_bib34","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.3390\/microorganisms10091733","article-title":"Do bacteria provide an alternative to cancer treatment and what role does lactic acid bacteria lay?","volume":"10","author":"Dicks","year":"2022","journal-title":"Microorganisms"},{"key":"2026061804164073400_bib35","doi-asserted-by":"publisher","first-page":"1278011","DOI":"10.3389\/fimmu.2023.1278011","article-title":"Listeria monocytogenes: a promising vector for tumor immunotherapy","volume":"14","author":"Ding","year":"2023","journal-title":"Front Immunol"},{"key":"2026061804164073400_bib36","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.3389\/fimmu.2019.02965","article-title":"The intriguing history of cancer immunotherapy","volume":"10","author":"Dobosz","year":"2019","journal-title":"Front Immunol"},{"key":"2026061804164073400_bib37","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s42452-025-07155-2","article-title":"The role of genomics and proteomics in drug discovery and its application in pharmacy","volume":"7","author":"Dogiparthi","year":"2025","journal-title":"Discov Appl Sci"},{"key":"2026061804164073400_bib38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0297-0","article-title":"Bacteria-cancer interactions: bacteria-based cancer therapy","volume":"51","author":"Duong","year":"2019","journal-title":"Exp Mol Med"},{"key":"2026061804164073400_bib39","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.biotechadv.2016.06.003","article-title":"Advances in chromobacterium violaceum and properties of violacein-its main secondary metabolite: a review","volume":"34","author":"Dur\u00e1n","year":"2016","journal-title":"Biotechnol Adv"},{"key":"2026061804164073400_bib40","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.2147\/IJN.S289443","article-title":"Nanocarriers-mediated drug delivery systems for anticancer agents: an overview and perspectives","volume":"16","author":"Edis","year":"2021","journal-title":"IJN"},{"key":"2026061804164073400_bib41","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/sj.bjc.6690451","article-title":"Mode of action of thiocoraline, a natural marine compound with anti-tumour activity","volume":"80","author":"Erba","year":"1999","journal-title":"Br J Cancer"},{"key":"2026061804164073400_bib42","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/anie.200390115","article-title":"Salinosporamide a: a highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus salinospora","volume":"42","author":"Feling","year":"2003","journal-title":"Angew Chem Int Ed"},{"key":"2026061804164073400_bib43","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3892\/ol.2020.12371","article-title":"Novel insights into the role of Clostridium novyi-NT related combination bacteriolytic therapy in solid tumors","volume":"21","author":"Feng","year":"2021","journal-title":"Oncol Lett"},{"key":"2026061804164073400_bib44","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nchembio841","article-title":"Developing a new resource for drug discovery: marine actinomycete bacteria","volume":"2","author":"Fenical","year":"2006","journal-title":"Nat Chem Biol"},{"key":"2026061804164073400_bib45","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s40425-018-0381-3","article-title":"White paper on microbial anti-cancer therapy and prevention","volume":"6","author":"Forbes","year":"2018","journal-title":"j immunotherapy cancer"},{"key":"2026061804164073400_bib46","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1038\/sj.bjc.6605403","article-title":"Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice","volume":"101","author":"Ganai","year":"2009","journal-title":"Br J Cancer"},{"key":"2026061804164073400_bib47","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1002\/pro.3310","article-title":"Bacterial cupredoxin azurin hijacks cellular signaling networks: protein-protein interactions and cancer therapy","volume":"26","author":"Gao","year":"2017","journal-title":"Protein Sci"},{"key":"2026061804164073400_bib48","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.micres.2012.02.008","article-title":"A novel anticancer and antifungus phenazine derivative from a marine actinomycete BM-17","volume":"167","author":"Gao","year":"2012","journal-title":"Microbiol Res"},{"key":"2026061804164073400_bib49","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.semcancer.2021.12.013","article-title":"Anticancer activity of lactic acid bacteria","volume":"86","author":"Garbacz","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"2026061804164073400_bib50","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41417-023-00715-x","article-title":"Redefining bioactive small molecules from microbial metabolites as revolutionary anticancer agents","volume":"31","author":"Giurini","year":"2024","journal-title":"Cancer Gene Ther"},{"key":"2026061804164073400_bib51","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.3390\/vaccines9121497","article-title":"Bacterial-based cancer therapy (BBCT): recent advances, current challenges, and future prospects for cancer immunotherapy","volume":"9","author":"Gupta","year":"2021","journal-title":"Vaccines"},{"key":"2026061804164073400_bib52","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/s41467-024-44776-4","article-title":"Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia","volume":"15","author":"Gurbatri","year":"2024","journal-title":"Nat Commun"},{"key":"2026061804164073400_bib53","doi-asserted-by":"publisher","first-page":"25149","DOI":"10.1039\/D4RA03911D","article-title":"Biopolymeric nanocarriers in cancer therapy: unleashing the potency of bioactive anticancer compounds for enhancing drug delivery","volume":"14","author":"Hadkar","year":"2024","journal-title":"RSC Adv"},{"key":"2026061804164073400_bib54","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1271\/bbb.60502","article-title":"Strong enhancement of recombinant cytosine deaminase activity in Bifidobacterium longum for tumor-targeting enzyme\/prodrug therapy","volume":"71","author":"Hamaji","year":"2007","journal-title":"Biosci Biotechnol Biochem"},{"key":"2026061804164073400_bib55","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrd4510","article-title":"The re-emergence of natural products for drug discovery in the genomics era","volume":"14","author":"Harvey","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"2026061804164073400_bib56","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"2026061804164073400_bib57","doi-asserted-by":"publisher","first-page":"pgad484","DOI":"10.1093\/pnasnexus\/pgad484","article-title":"Infection of tumor cells with Salmonella typhimurium mimics immunogenic cell death and elicits tumor-specific immune responses","volume":"3","author":"Horiuchi","year":"2024","journal-title":"PNAS Nexus"},{"key":"2026061804164073400_bib58","first-page":"105","article-title":"Evaluation of the cytotoxicity of secondary bioactive compounds produced by Streptomyces in soil against a colon cancer cell line","volume":"13","author":"Hosseini","year":"2024","journal-title":"Int J Mol Cell Med"},{"key":"2026061804164073400_bib59","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3390\/molecules28030927","article-title":"Classification and multifaceted potential of secondary metabolites produced by Bacillus subtilis group: a comprehensive review","volume":"28","author":"Iqbal","year":"2023","journal-title":"Molecules"},{"key":"2026061804164073400_bib60","doi-asserted-by":"publisher","first-page":"123099","DOI":"10.1016\/j.ijpharm.2023.123099","article-title":"Targeted bacteria-mediated therapy of mouse colorectal cancer using baicalin, a natural glucuronide compound, and E. coli overexpressing \u03b2-glucuronidase","volume":"642","author":"Jafari","year":"2023","journal-title":"Int J Pharm"},{"key":"2026061804164073400_bib61","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/bbb\/zbae036","article-title":"Anti-cancer effects of plant-derived micromonospora sp. M2 against A549 and MCF-7 cell lines","volume":"88","author":"Jeong","year":"2024","journal-title":"Biosci Biotechnol Biochem"},{"key":"2026061804164073400_bib62","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/ja.2006.33","article-title":"Streptokordin, a new cytotoxic compound of the methylpyridine class from a marine-derived streptomyces sp. KORDI-3238","volume":"59","author":"Jeong","year":"2006","journal-title":"J Antibiot"},{"key":"2026061804164073400_bib63","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13040-025-00442-z","article-title":"Network-based multi-omics integrative analysis methods in drug discovery: a systematic review","volume":"18","author":"Jiang","year":"2025","journal-title":"BioData Mining"},{"key":"2026061804164073400_bib64","doi-asserted-by":"publisher","first-page":"143723","DOI":"10.1016\/j.ijbiomac.2025.143723","article-title":"Evaluating the potential of Halomonas pacifica DJ6.1 L-asparaginase: statistical production optimization, biochemical characterization and anticancer attributes using Caco-2 cell lines","volume":"311","author":"Joshi","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"2026061804164073400_bib65","doi-asserted-by":"publisher","first-page":"20251076","DOI":"10.1515\/biol-2025-1076","article-title":"Oncolytic bacteria: a revolutionary approach to cancer therapy","volume":"20","author":"Khormi","year":"2025","journal-title":"Open Life Sci"},{"key":"2026061804164073400_bib66","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.febslet.2007.01.059","article-title":"Surfactin from Bacillus subtilis displays anti-proliferative effect via apoptosis induction, cell cycle arrest and survival signaling suppression","volume":"581","author":"Kim","year":"2007","journal-title":"FEBS Lett"},{"key":"2026061804164073400_bib67","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s40425-019-0601-5","article-title":"Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodies","volume":"7","author":"Kim","year":"2019","journal-title":"J Immunother Cancer"},{"key":"2026061804164073400_bib68","doi-asserted-by":"publisher","first-page":"10731","DOI":"10.3390\/ijms221910731","article-title":"The natural pigment violacein potentially suppresses the proliferation and stemness of hepatocellular carcinoma cells in vitro","volume":"22","author":"Kim","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026061804164073400_bib69","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/carcin\/bgi307","article-title":"Violacein synergistically increases 5-fluorouracil cytotoxicity, induces apoptosis and inhibits Akt-mediated signal transduction in human colorectal cancer cells","volume":"27","author":"Kodach","year":"2006","journal-title":"Carcinogenesis"},{"key":"2026061804164073400_bib70","doi-asserted-by":"publisher","first-page":"1551924","DOI":"10.3389\/fonc.2025.1551924","article-title":"Application of bifidobacterium in tumor therapy","volume":"15","author":"Kong","year":"2025","journal-title":"Front Oncol"},{"key":"2026061804164073400_bib71","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12935-022-02656-1","article-title":"Induction of apoptosis and cell cycle arrest in colorectal cancer cells by novel anticancer metabolites of Streptomyces sp. 801","volume":"22","author":"Kouroshnia","year":"2022","journal-title":"Cancer Cell Int"},{"key":"2026061804164073400_bib72","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1021\/ja0558948","article-title":"Marinomycins a-D, antitumor-antibiotics of a new structure class from a marine actinomycete of the recently discovered genus \u201cmarinispora","volume":"128","author":"Kwon","year":"2006","journal-title":"J Am Chem Soc"},{"key":"2026061804164073400_bib73","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/gt.2013.86","article-title":"Salmonella induce autophagy in melanoma by the downregulation of AKT\/mTOR pathway","volume":"21","author":"Lee","year":"2014","journal-title":"Gene Ther"},{"key":"2026061804164073400_bib74","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41522-025-00786-8","article-title":"Gut microbiota shapes cancer immunotherapy responses","volume":"11","author":"Lei","year":"2025","journal-title":"npj Biofilms Microbiomes"},{"key":"2026061804164073400_bib75","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.copbio.2020.12.011","article-title":"Refactoring biosynthetic gene clusters for heterologous production of microbial natural products","volume":"69","author":"Li","year":"2021","journal-title":"Curr Opin Biotechnol"},{"key":"2026061804164073400_bib76","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.resmic.2018.11.001","article-title":"Expressing cytotoxic compounds in Escherichia coli Nissle 1917 for tumor-targeting therapy","volume":"170","author":"Li","year":"2019","journal-title":"Res Microbiol"},{"key":"2026061804164073400_bib77","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1021\/acssynbio.1c00631","article-title":"Reprogramming synthetic cells for targeted cancer therapy","volume":"11","author":"Lim","year":"2022","journal-title":"ACS Synth Biol"},{"key":"2026061804164073400_bib78","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s44321-023-00022-w","article-title":"Bacteria colonization in tumor microenvironment creates a favorable niche for immunogenic chemotherapy","volume":"16","author":"Lim","year":"2024","journal-title":"EMBO Mol Med"},{"key":"2026061804164073400_bib79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejbt.2019.04.007","article-title":"Enhanced production of prodigiosin by Serratia marcescens FZSF02 in the form of pigment pellets","volume":"40","author":"Lin","year":"2019","journal-title":"Electron J Biotechnol"},{"key":"2026061804164073400_bib80","first-page":"12","article-title":"In situ immunomodulation of tumors with biosynthetic bacteria promote anti-tumor immunity","volume":"32","author":"Lin","year":"2023","journal-title":"Bioact Mater"},{"key":"2026061804164073400_bib81","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/sj.gt.3301659","article-title":"Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia\/necrosis","volume":"9","author":"Liu","year":"2002","journal-title":"Gene Ther"},{"key":"2026061804164073400_bib82","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/md22010051","article-title":"Marine streptomyces-derived novel alkaloids discovered in the past decade","volume":"22","author":"Liu","year":"2024","journal-title":"Mar Drugs"},{"key":"2026061804164073400_bib83","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.chom.2025.12.011","article-title":"The yin and yang of bacterial asn in tumor biology","volume":"34","author":"Lobel","year":"2026","journal-title":"Cell Host Microbe"},{"key":"2026061804164073400_bib84","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3727\/096504001108747512","article-title":"Antitumor effect of VNP20009, an attenuated Salmonella, in murine tumor models","volume":"12","author":"Luo","year":"2001","journal-title":"Oncol Res"},{"key":"2026061804164073400_bib85","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1021\/np060621r","article-title":"Marmycins a and B, cytotoxic pentacyclic C-glycosides from a marine sediment-derived actinomycete related to the genus Streptomyces","volume":"70","author":"Martin","year":"2007","journal-title":"J Nat Prod"},{"key":"2026061804164073400_bib86","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/s41429-020-0330-5","article-title":"Highlights of marine natural products having parallel scaffolds found from marine-derived bacteria, sponges, and tunicates","volume":"73","author":"McCauley","year":"2020","journal-title":"J Antibiot"},{"key":"2026061804164073400_bib87","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41576-021-00363-7","article-title":"Mining genomes to illuminate the specialized chemistry of life","volume":"22","author":"Medema","year":"2021","journal-title":"Nat Rev Genet"},{"key":"2026061804164073400_bib88","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1021\/jo061064g","article-title":"Piperazimycins: cytotoxic hexadepsipeptides from a marine-derived bacterium of the genus Streptomyces","volume":"72","author":"Miller","year":"2007","journal-title":"J Org Chem"},{"key":"2026061804164073400_bib89","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity","volume":"56","author":"Minotti","year":"2004","journal-title":"Pharmacol Rev"},{"key":"2026061804164073400_bib90","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3390\/toxins17090459","article-title":"Bacterial protein toxins as anticancer agents: clinical potential of Pseudomonas and Anthrax toxins","volume":"17","author":"Misra","year":"2025","journal-title":"Toxins"},{"key":"2026061804164073400_bib91","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.semcancer.2021.05.006","article-title":"Bacteria as a treasure house of secondary metabolites with anticancer potential","volume":"86","author":"Mohan","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"2026061804164073400_bib92","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s00262-022-03148-x","article-title":"Inflammasome activation, NLRP3 engagement and macrophage recruitment to tumor microenvironment are all required for Salmonella antitumor effect","volume":"71","author":"M\u00f3naco","year":"2022","journal-title":"Cancer Immunol Immunother"},{"key":"2026061804164073400_bib93","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s40588-019-00133-4","article-title":"Listeria monocytogenes cancer vaccines: bridging innate and adaptive immunity","volume":"6","author":"Morrow","year":"2019","journal-title":"Curr Clin Micro Rpt"},{"key":"2026061804164073400_bib94","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41417-021-00296-7","article-title":"Use of an optimised enzyme\/prodrug combination for Clostridia directed enzyme prodrug therapy induces a significant growth delay in necrotic tumours","volume":"29","author":"Mowday","year":"2022","journal-title":"Cancer Gene Ther"},{"key":"2026061804164073400_bib95","first-page":"e69113","article-title":"William Coley: the pioneer and the father of immunotherapy","volume":"16","author":"Munir","year":"2024","journal-title":"Cureus"},{"key":"2026061804164073400_bib96","doi-asserted-by":"publisher","first-page":"8367","DOI":"10.3390\/molecules27238367","article-title":"Natural products as anticancer agents: current status and future perspectives","volume":"27","author":"Naeem","year":"2022","journal-title":"Molecules"},{"key":"2026061804164073400_bib97","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1038\/s41467-023-39224-8","article-title":"Bioengineering of bacteria for cancer immunotherapy","volume":"14","author":"Nguyen","year":"2023","journal-title":"Nat Commun"},{"key":"2026061804164073400_bib98","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3390\/md7020210","article-title":"Antitumor compounds from marine actinomycetes","volume":"7","author":"Olano","year":"2009","journal-title":"Mar Drugs"},{"key":"2026061804164073400_bib99","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3390\/biomedicines9111566","article-title":"Highlights of immunomodulation in Salmonella-based cancer therapy","volume":"9","author":"Pangilinan","year":"2021","journal-title":"Biomedicines"},{"key":"2026061804164073400_bib100","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J Nanobiotechnol"},{"key":"2026061804164073400_bib101","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1423-0127-17-21","article-title":"Bacteria in cancer therapy: a novel experimental strategy","volume":"17","author":"Patyar","year":"2010","journal-title":"J Biomed Sci"},{"key":"2026061804164073400_bib102","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.3389\/fmicb.2019.01404","article-title":"A review of the microbial production of bioactive natural products and biologics","volume":"10","author":"Pham","year":"2019","journal-title":"Front Microbiol"},{"key":"2026061804164073400_bib103","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.copbio.2015.05.004","article-title":"Engineered bacteria as therapeutic agents","volume":"35","author":"Pi\u00f1ero-Lambea","year":"2015","journal-title":"Curr Opin Biotechnol"},{"key":"2026061804164073400_bib104","doi-asserted-by":"publisher","first-page":"21102","DOI":"10.1074\/jbc.M116.774836","article-title":"The natural product mensacarcin induces mitochondrial toxicity and apoptosis in melanoma cells","volume":"292","author":"Plitzko","year":"2017","journal-title":"J Biol Chem"},{"key":"2026061804164073400_bib105","doi-asserted-by":"publisher","first-page":"e2000024","DOI":"10.1002\/cbdv.202000024","article-title":"Secondary metabolites from marine micromonospora: chemistry and bioactivities","volume":"17","author":"Qi","year":"2020","journal-title":"Chem Biodivers"},{"key":"2026061804164073400_bib106","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.chom.2025.12.003","article-title":"Microbiota utilization of intestinal amino acids modulates cancer progression and anticancer immunity","volume":"34","author":"Qiao","year":"2026","journal-title":"Cell Host Microbe"},{"key":"2026061804164073400_bib107","first-page":"445","article-title":"Cytotoxic compounds from marine actinomycetes: sources, structures and bioactivity","volume":"1","author":"Qiu","year":"2022","journal-title":"Acta Mater Med"},{"key":"2026061804164073400_bib108","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrurol.2014.15","article-title":"The mechanism of action of BCG therapy for bladder cancer: a current perspective","volume":"11","author":"Redelman-Sidi","year":"2014","journal-title":"Nat Rev Urol"},{"key":"2026061804164073400_bib109","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41586-024-08033-4","article-title":"Probiotic neoantigen delivery vectors for precision cancer immunotherapy","volume":"635","author":"Redenti","year":"2024","journal-title":"Nature"},{"key":"2026061804164073400_bib110","doi-asserted-by":"publisher","first-page":"4814","DOI":"10.3390\/molecules27154814","article-title":"Marine cyanobacteria as sources of lead anticancer compounds: a review of families of metabolites with cytotoxic, antiproliferative, and antineoplastic effects","volume":"27","author":"Robles-Ba\u00f1uelos","year":"2022","journal-title":"Molecules"},{"key":"2026061804164073400_bib111","doi-asserted-by":"publisher","first-page":"100484","DOI":"10.4251\/wjgo.v17.i4.100484","article-title":"Natural products and cancer: the urgent need to bridge the gap between preclinical and clinical research","volume":"17","author":"Rojas","year":"2025","journal-title":"World J Gastrointest Oncol"},{"key":"2026061804164073400_bib112","doi-asserted-by":"publisher","first-page":"1550516","DOI":"10.3389\/fmicb.2025.1550516","article-title":"Biological activity of secondary metabolites of Actinomycetes and their potential sources as antineoplastic drugs: a review","volume":"16","author":"Rui","year":"2025","journal-title":"Front Microbiol"},{"key":"2026061804164073400_bib113","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrmicro3496","article-title":"Discovery of microbial natural products by activation of silent biosynthetic gene clusters","volume":"13","author":"Rutledge","year":"2015","journal-title":"Nat Rev Micro"},{"key":"2026061804164073400_bib114","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1472-6882-13-29","article-title":"Cytotoxic and apoptotic evaluations of marine bacteria isolated from brine-seawater interface of the Red Sea","volume":"13","author":"Sagar","year":"2013","journal-title":"BMC Complement Altern Med"},{"key":"2026061804164073400_bib115","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/j.1349-7006.2006.00221.x","article-title":"Genetically engineered Bifidobacterium longum for tumor-targeting enzyme-prodrug therapy of autochthonous mammary tumors in rats","volume":"97","author":"Sasaki","year":"2006","journal-title":"Cancer Sci"},{"key":"2026061804164073400_bib116","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.3390\/molecules28031368","article-title":"Recent developments in the biological activities, bioproduction, and applications of Pseudomonas spp. Phenazines","volume":"28","author":"Serafim","year":"2023","journal-title":"Molecules"},{"key":"2026061804164073400_bib117","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12860-024-00517-5","article-title":"Evaluation of antibacterial and anticancer properties of secondary metabolites isolated from soil Bacillus spp focusing on two strains of Bacillus licheniformis and Bacillus siamensis","volume":"25","author":"Shahniani","year":"2024","journal-title":"BMC Mol and Cell Biol"},{"key":"2026061804164073400_bib118","doi-asserted-by":"publisher","first-page":"682","DOI":"10.2174\/1568009623666230413094253","article-title":"Therapeutic potential of Clostridium novyi-NT in cancer: current knowledge and future perspectives","volume":"23","author":"Sharafabad","year":"2023","journal-title":"CCDT"},{"key":"2026061804164073400_bib119","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1186\/s12906-024-04742-5","article-title":"The ability of Clostridium novyi-NT spores to induce apoptosis via the mitochondrial pathway in mice with HPV-positive cervical cancer tumors derived from the TC-1 cell line","volume":"24","author":"Sharafabad","year":"2024","journal-title":"BMC Complement Med Ther"},{"key":"2026061804164073400_bib120","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3390\/epidemiologia5040053","article-title":"Global, regional, and national burden of tracheal, bronchus, and lung cancer in 2022: evidence from the GLOBOCAN study","volume":"5","author":"Sharma","year":"2024","journal-title":"Epidemiologia"},{"key":"2026061804164073400_bib121","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12896-025-00991-5","article-title":"Exploring the mechanisms and mode of action of bioactive compounds from marine streptomyces albidoflavus against breast carcinoma cells","volume":"25","author":"Shata","year":"2025","journal-title":"BMC Biotechnol"},{"key":"2026061804164073400_bib122","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1039\/D2BM01593E","article-title":"Engineered bacteria for augmented in situ tumor vaccination","volume":"11","author":"Shen","year":"2023","journal-title":"Biomater Sci"},{"key":"2026061804164073400_bib123","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1586\/14760584.5.4.541","article-title":"Listeria monocytogenes as a vector for tumor-associated antigens for cancer immunotherapy","volume":"5","author":"Singh","year":"2006","journal-title":"Expert Rev Vaccines"},{"key":"2026061804164073400_bib124","first-page":"465","article-title":"Anti-cancer strategies using anaerobic spore-forming bacteria Clostridium: advances and synergistic approaches","volume":"15","author":"Singh","year":"2025","journal-title":"Life (Basel)"},{"key":"2026061804164073400_bib125","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1378\/chest.120.2.617","article-title":"Bleomycin-induced pneumonitis","volume":"120","author":"Sleijfer","year":"2001","journal-title":"Chest"},{"key":"2026061804164073400_bib126","doi-asserted-by":"publisher","first-page":"105795","DOI":"10.1016\/j.micpath.2022.105795","article-title":"Future prospects of bacteria-mediated cancer therapies: affliction or opportunity?","volume":"172","author":"Soleimani","year":"2022","journal-title":"Microb Pathog"},{"key":"2026061804164073400_bib127","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41429-020-0307-4","article-title":"Chlorinated bis-indole alkaloids from deep-sea derived streptomyces sp. SCSIO 11791 with antibacterial and cytotoxic activities","volume":"73","author":"Song","year":"2020","journal-title":"J Antibiot"},{"key":"2026061804164073400_bib128","doi-asserted-by":"publisher","first-page":"9291","DOI":"10.1007\/s00253-013-5229-7","article-title":"Culturable rare actinomycetes: diversity, isolation and marine natural product discovery","volume":"97","author":"Subramani","year":"2013","journal-title":"Appl Microbiol Biotechnol"},{"key":"2026061804164073400_bib129","doi-asserted-by":"publisher","first-page":"5546","DOI":"10.7150\/thno.87340","article-title":"Engineered oncolytic bacteria HCS1 exerts high immune stimulation and safety profiles for cancer therapy","volume":"13","author":"Sun","year":"2023","journal-title":"Theranostics"},{"key":"2026061804164073400_bib130","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2026061804164073400_bib131","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.2147\/IJN.S315650","article-title":"Bifidobacterium bifidum-mediated specific delivery of nanoparticles for tumor ttherapy","volume":"16","author":"Tang","year":"2021","journal-title":"IJN"},{"key":"2026061804164073400_bib132","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1021\/acsmeasuresciau.4c00062","article-title":"Revolutionizing cancer immunotherapy: emerging nanotechnology-driven drug delivery systems for enhanced therapeutic efficacy","volume":"5","author":"Theivendren","year":"2024","journal-title":"ACS Meas Sci Au"},{"key":"2026061804164073400_bib133","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.3390\/cancers16223810","article-title":"Harnessing bacterial agents to modulate the tumor microenvironment and enhance cancer immunotherapy","volume":"16","author":"Thomas","year":"2024","journal-title":"Cancers"},{"key":"2026061804164073400_bib134","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s10295-019-02198-y","article-title":"Advances in microbial culturing conditions to activate silent biosynthetic gene clusters for novel metabolite production","volume":"46","author":"Tomm","year":"2019","journal-title":"J Ind Microbiol Biotechnol"},{"key":"2026061804164073400_bib135","doi-asserted-by":"publisher","first-page":"1434137","DOI":"10.3389\/fphar.2024.1434137","article-title":"Strategies for the development of stimuli-responsive small molecule prodrugs for cancer treatment","volume":"15","author":"Tu","year":"2024","journal-title":"Front Pharmacol"},{"key":"2026061804164073400_bib136","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2174\/0118715206399680250814104403","article-title":"Microbial-derived anti-cancer compounds: advances in drug discovery, bioengineering, and therapeutic applications","volume":"26","author":"Tyagi","year":"2026","journal-title":"ACAMC"},{"key":"2026061804164073400_bib137","doi-asserted-by":"publisher","first-page":"862764","DOI":"10.1155\/2012\/862764","article-title":"Clostridial spores for cancer therapy: targeting solid tumour microenvironment","volume":"2012","author":"Umer","year":"2012","journal-title":"J Toxicol"},{"key":"2026061804164073400_bib138","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1038\/s44319-025-00386-9","article-title":"Modulating tumor immunity using advanced microbiome therapeutics producing an indole metabolite","volume":"26","author":"Vaaben","year":"2025","journal-title":"EMBO Rep"},{"key":"2026061804164073400_bib139","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"key":"2026061804164073400_bib140","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41368-024-00282-3","article-title":"Promising dawn in tumor microenvironment therapy: engineering oral bacteria","volume":"16","author":"Wang","year":"2024","journal-title":"Int J Oral Sci"},{"key":"2026061804164073400_bib141","doi-asserted-by":"publisher","first-page":"108605","DOI":"10.1016\/j.pharmthera.2024.108605","article-title":"Harnessing and delivering microbial metabolites as therapeutics via advanced pharmaceutical approaches","volume":"256","author":"Williams","year":"2024","journal-title":"Pharmacol Ther"},{"key":"2026061804164073400_bib142","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1021\/np0604580","article-title":"Saliniketals a and B, bicyclic polyketides from the marine actinomycete Salinispora arenicola","volume":"70","author":"Williams","year":"2007","journal-title":"J Nat Prod"},{"key":"2026061804164073400_bib143","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/s41423-025-01326-2","article-title":"The gut microbiota in cancer immunity and immunotherapy","volume":"22","author":"Xie","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"2026061804164073400_bib144","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.3389\/fonc.2020.01303","article-title":"p28 bacterial peptide, as an anticancer agent","volume":"10","author":"Yaghoubi","year":"2020","journal-title":"Front Oncol"},{"key":"2026061804164073400_bib145","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.phytochem.2016.12.010","article-title":"Antiproliferative cyclodepsipeptides from the marine actinomycete streptomyces sp. P11\u201323B downregulating the tumor metabolic enzymes of glycolysis, glutaminolysis, and lipogenesis","volume":"135","author":"Ye","year":"2017","journal-title":"Phytochemistry"},{"key":"2026061804164073400_bib146","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.mib.2019.03.003","article-title":"Unlocking the trove of metabolic treasures: activating silent biosynthetic gene clusters in bacteria and fungi","volume":"51","author":"Zhang","year":"2019","journal-title":"Curr Opin Microbiol"},{"key":"2026061804164073400_bib147","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3390\/md14100181","article-title":"New metabolites and bioactive actinomycins from marine-derived streptomyces sp. ZZ338","volume":"14","author":"Zhang","year":"2016","journal-title":"Mar Drugs"},{"key":"2026061804164073400_bib148","doi-asserted-by":"publisher","first-page":"54616","DOI":"10.18632\/oncotarget.17605","article-title":"Toxicology and efficacy of tumor-targeting Salmonella typhimurium A1-R compared to VNP 20009 in a syngeneic mouse tumor model in immunocompetent mice","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"2026061804164073400_bib149","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13568-018-0606-3","article-title":"Potential of Bacillus subtilis lipopeptides in anti-cancer I: induction of apoptosis and paraptosis and inhibition of autophagy in K562 cells","volume":"8","author":"Zhao","year":"2018","journal-title":"AMB Expr"},{"key":"2026061804164073400_bib150","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.3390\/pharmaceutics15092214","article-title":"Bacterial drug delivery systems for cancer therapy: \u201cwhy\u201d and \u201chow","volume":"15","author":"Zhao","year":"2023","journal-title":"Pharmaceutics"},{"key":"2026061804164073400_bib151","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41568-018-0070-z","article-title":"Tumour-targeting bacteria engineered to fight cancer","volume":"18","author":"Zhou","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"2026061804164073400_bib152","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.3390\/molecules26113453","article-title":"Pharmacological activities of aminophenoxazinones","volume":"26","author":"Zorrilla","year":"2021","journal-title":"Molecules"}],"container-title":["Letters in Applied Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/lambio\/advance-article-pdf\/doi\/10.1093\/lambio\/ovag050\/68475052\/ovag050.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/lambio\/article-pdf\/79\/6\/ovag050\/68475052\/ovag050.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/lambio\/article-pdf\/79\/6\/ovag050\/68475052\/ovag050.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:16:49Z","timestamp":1781770609000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/lambio\/article\/doi\/10.1093\/lambio\/ovag050\/8702395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":152,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,12]]}},"URL":"https:\/\/doi.org\/10.1093\/lambio\/ovag050","relation":{},"ISSN":["1472-765X"],"issn-type":[{"value":"1472-765X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,6]]},"article-number":"ovag050"}}